Effects of Losartan or Combined with Benazepril on the BP and \;AngiotensinII in Hypertension
Yunxiao Xu
Abstract
Yunxiao Xu
Abstract
Aim: To evaluate the effects and safety of losartan on the blood pressure,left ventricular remodeling and angiotensin Ⅱ in treatment of essential hypertension. Methods: 90 patients were randomly divided into three groups: 30 patients treated with losartan (50~100 mg qd), 30 patients treated with benazepril(10 mg qd), 30 patients treated with combination of losartan and benazepril(50 mg qd and 5 mg qd), all groups were treated for 6 weeks. Results: According to office blood pressure or ambulatory blood pressure measurment the overall efficacy rate of losartan and benazepril was 90% and 86.6% respectively, and combination group was 96.6%. No statistical singnificant difference among the three groups was found( P 0.05). Losartan caused increases in serum angiotensinⅡ; benazepril caused decreases in serum angiotensin Ⅱ( P0.01 vs before treatment).The adverse reaction rate of losartan and benazepril was 12.5% and 23.3% respectively, and the combination group was 13.3%. Benazepril group seems to have higher adverse drug reaction rate( P 0.01). Conclusion:Losartan is effective and safe in treatment of hypertension.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim: To evaluate the effects and safety of losartan on the blood pressure,left ventricular remodeling and angiotensin Ⅱ in treatment of essential hypertension. Methods: 90 patients were randomly divided into three groups: 30 patients treated with losartan (50~100 mg qd), 30 patients treated with benazepril(10 mg qd), 30 patients treated with combination of losartan and benazepril(50 mg qd and 5 mg qd), all groups were treated for 6 weeks. Results: According to office blood pressure or ambulatory blood pressure measurment the overall efficacy rate of losartan and benazepril was 90% and 86.6% respectively, and combination group was 96.6%. No statistical singnificant difference among the three groups was found( P 0.05). Losartan caused increases in serum angiotensinⅡ; benazepril caused decreases in serum angiotensin Ⅱ( P0.01 vs before treatment).The adverse reaction rate of losartan and benazepril was 12.5% and 23.3% respectively, and the combination group was 13.3%. Benazepril group seems to have higher adverse drug reaction rate( P 0.01). Conclusion:Losartan is effective and safe in treatment of hypertension.
Key concepts: Benazepril, Losartan, Medicine, Blood pressure, Ambulatory blood pressure, Internal medicine, Angiotensin II, Essential hypertension